Company / R&D per Share
Centessa Pharmaceuticals plc R&D per Share History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$1.15
FY2025
5-year range
$1.13 / $1.66
FY2021-FY2025
Trend
+1.9%
vs FY2024
Sector context
#141 of 208
Health Care
What the data says
At $1.15, Centessa Pharmaceuticals plc's r&d per share ranks #141 of 208 in the Health Care sector. R&D per Share returned to growth in FY2025 after 2 years of decline, reaching $1.15.
Based on SEC 10-K filings.
1.15 in FY2025 with a 3-year CAGR of -11.4%.
Declined from $1.31 to $1.15 over the past 2 years.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- -11.4%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#141 of 208 in Health CareTop 68% of 208This company $1.15 Sector average $28.77
▼
-96.0% below sector average
Key checks
Key Insights
- In FY2025, r&d per share increased 1.9% year-over-year.
- Ranks #141 out of 208 companies in the Health Care sector.
- Peak r&d per share was recorded in FY2022.
- Lowest r&d per share in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score 0.80 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.15 | +1.9% |
| FY2024 | $1.13 | -13.6% |
| FY2023 | $1.31 | -21.0% |
| FY2022 | $1.66 | +30.5% |
| FY2021 | $1.27 | - |
| FY2020 | - | - |
| FY2019 | - | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026